Correlation between response to acyclovir and foscarnet therapy and in vitro susceptibility result for isolates of herpes simplex virus from human immunodeficiency virus-infected patients.

@article{Safrin1994CorrelationBR,
  title={Correlation between response to acyclovir and foscarnet therapy and in vitro susceptibility result for isolates of herpes simplex virus from human immunodeficiency virus-infected patients.},
  author={Sharon Safrin and Tarek A Elbeik and Long T. Phan and David Robinson and Joel Rush and Ahmed Elbaggari and John Mills},
  journal={Antimicrobial agents and chemotherapy},
  year={1994},
  volume={38 6},
  pages={1246-50}
}
In vitro susceptibility testing of herpes simplex virus (HSV) isolates will play an increasingly important role in guiding the clinical management of immunocompromised hosts who have lesions that are poorly responsive to therapy with standard antiviral agents. We assessed the correlation between the in vitro susceptibility result using a plaque reduction assay in Vero cells and the response to antiviral therapy with acyclovir or foscarnet for 243 clinical isolates of HSV collected from 115… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 26 extracted citations

Management of herpes simplex virus type 2 infection in HIV type 1-infected persons.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America • 2006
View 4 Excerpts
Highly Influenced

Similar Papers

Loading similar papers…